Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Severe hypoglycaemia raises risk of heart failure in adults with T2D
Severe hypoglycaemia may contribute to a higher risk of incident heart failure (HF) among adults with type 2 diabetes (T2D), reports a study.
Severe hypoglycaemia raises risk of heart failure in adults with T2D
08 Mar 2022
Weight loss in T2D patients ups death risk, but lifestyle change can help
Mortality is heightened among type 2 diabetes (T2D) patients with substantial weight loss, but such risk can be attenuated by improving lifestyle quality, suggests a recent study.
Weight loss in T2D patients ups death risk, but lifestyle change can help
06 Mar 2022
Telehealth disappoints as mental health support for T1D during pandemic
Telehealth strategies do not seem to ease the mental health burden in type 1 diabetes (T1D) patients during the coronavirus disease 2019 (COVID-19) pandemic, reports a recent Brazil study.
Telehealth disappoints as mental health support for T1D during pandemic
06 Mar 2022
T2D risk elevated in thyroid cancer patients after thyroidectomy
Development of type 2 diabetes (T2D) is more likely to occur among patients with thyroid cancer who underwent thyroidectomy than matched controls, a Korea study has shown. In addition, a U-shaped dose-dependent relationship exists between the levothyroxine dosage and T2D risk.
T2D risk elevated in thyroid cancer patients after thyroidectomy
05 Mar 2022
T2D: Risk of CV and all-cause mortality lower with SGLT2 vs DPP-4 inhibitors
A real-world propensity score-matched study in Hong Kong finds that, compared with use of dipeptidyl peptidase-4 (DPP-4) inhibitors, use of sodium-glucose cotransporter 2 (SGLT2) inhibitors in type 2 diabetes (T2D) patients is associated with lower risk of incident atrial fibrillation (AF), stroke/transient ischaemic attack (TIA), and cardiovascular (CV) and all-cause mortality.
T2D: Risk of CV and all-cause mortality lower with SGLT2 vs DPP-4 inhibitors
05 Mar 2022
Minor changes in glucose levels first week after COVID-19 vaccine
Patients with type 1 diabetes mellitus (T1DM) may experience a temporary change in their blood glucose levels in the first week following COVID-19 vaccination, according to a small English study.